PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 45.49
+1.09 (2.45%)
At close: May 12, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 6.26 billion as of May 12, 2026. Its market cap has increased by 73.56% in one year.
Market Cap
6.26B
Enterprise Value
6.13B
Revenue
691.21M
Ranking
n/a
PE Ratio
142.69
Stock Price
45.49
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 6.26B, an increase of 58.87%. That is a compound annual growth rate of 14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 6.26B | 52.29% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Huaheng Biotechnology | 6.84B |
| Innovita Biological Technology | 6.83B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.19B |
| Novogene | 6.12B |
| Hangzhou Biotest Biotech | 6.08B |
| R&G PharmaStudies | 5.87B |
| Lifecome Biochemistry | 5.86B |
| Shenzhen Weiguang Biological Products | 5.85B |